Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?

Literature DB >> 20952769

Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?

Maarten P van den Berg¹, Karin Y van Spaendonck-Zwarts, Dirk J van Veldhuisen, Jourik A Gietema, Aleida Postma, J Peter van Tintelen.

Abstract

Entities: Chemical Disease Mutation

Mesh：

Substances：

Year: 2010 PMID： 20952769 DOI： 10.1093/eurjhf/hfq175

Source DB: PubMed Journal: Eur J Heart Fail ISSN： 1388-9842 Impact factor: 15.534

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Clinical Application of Genetic Testing in Heart Failure.

Authors: Ana Morales; Ray Hershberger
Journal: Curr Heart Fail Rep Date: 2017-12

Review 2. Cardio-Oncology in Childhood: State of the Art.

Authors: Elena Bennati; Francesca Girolami; Gaia Spaziani; Giovanni Battista Calabri; Claudio Favre; Iris Parrini; Fabiana Lucà; Angela Tamburini; Silvia Favilli
Journal: Curr Oncol Rep Date: 2022-10-01 Impact factor: 5.945

Review 3. Genetics of cancer therapy-associated cardiotoxicity.

Authors: Yuri Kim; Jonathan G Seidman; Christine E Seidman
Journal: J Mol Cell Cardiol Date: 2022-03-28 Impact factor: 5.763

4. Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy.

Authors: Marijke Wasielewski; Karin Y van Spaendonck-Zwarts; Nico-Derk L Westerink; Jan D H Jongbloed; Aleida Postma; Jourik A Gietema; J Peter van Tintelen; Maarten P van den Berg
Journal: Open Heart Date: 2014-07-18

5. Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy.

Authors: Daniel J Serie; Julia E Crook; Brian M Necela; Bianca C Axenfeld; Travis J Dockter; Gerardo Colon-Otero; Edith A Perez; E Aubrey Thompson; Nadine Norton
Journal: J Cardiovasc Dev Dis Date: 2017-05-04

6. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.

Authors: Pablo Garcia-Pavia; Yuri Kim; Maria Alejandra Restrepo-Cordoba; Ida G Lunde; Hiroko Wakimoto; Amanda M Smith; Christopher N Toepfer; Kelly Getz; Joshua Gorham; Parth Patel; Kaoru Ito; Jonathan A Willcox; Zoltan Arany; Jian Li; Anjali T Owens; Risha Govind; Beatriz Nuñez; Erica Mazaika; Antoni Bayes-Genis; Roddy Walsh; Brian Finkelman; Josep Lupon; Nicola Whiffin; Isabel Serrano; William Midwinter; Alicja Wilk; Alfredo Bardaji; Nathan Ingold; Rachel Buchan; Upasana Tayal; Domingo A Pascual-Figal; Antonio de Marvao; Mian Ahmad; Jose Manuel Garcia-Pinilla; Antonis Pantazis; Fernando Dominguez; A John Baksi; Declan P O'Regan; Stuart D Rosen; Sanjay K Prasad; Enrique Lara-Pezzi; Mariano Provencio; Alexander R Lyon; Luis Alonso-Pulpon; Stuart A Cook; Steven R DePalma; Paul J R Barton; Richard Aplenc; Jonathan G Seidman; Bonnie Ky; James S Ware; Christine E Seidman
Journal: Circulation Date: 2019-04-16 Impact factor: 29.690

7. Case series, chemotherapy-induced cardiomyopathy: mind the family history!

Authors: Setareh Moghadasi; Rienke Fijn; Saskia L M A Beeres; Hennie Bikker; Jan D H Jongbloed; Djike Josephus Jitta; Judith R Kroep; Ronald H Lekanne Deprez; Yvonne J Vos; Mariëlle J M de Vreede; M Louisa Antoni; Daniela Q C M Barge-Schaapveld
Journal: Eur Heart J Case Rep Date: 2021-09-15